Enanta Pharmaceuticals Inc (ENTA): EPS (Diluted)
-$3.84
Year ended 2025-09-30
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$3.84 | n/m | 2025-11-19, From 2024-10-01 |
| 2024-09-30 | -$5.48 | n/m | 2025-11-19, From 2023-10-01 |
| 2023-09-30 | -$6.38 | n/m | 2025-11-19, From 2022-10-01 |
| 2022-09-30 | -$5.91 | n/m | 2024-11-27, From 2021-10-01 |
| 2021-09-30 | -$3.92 | n/m | 2023-11-22, From 2020-10-01 |
| 2020-09-30 | -$1.81 | n/m | 2022-11-23, From 2019-10-01 |
| 2019-09-30 | $2.21 | -36.5% | 2021-11-24, From 2018-10-01 |
| 2018-09-30 | $3.48 | +282.4% | 2020-11-25, From 2017-10-01 |
| 2017-09-30 | $0.91 | -19.5% | 2019-11-27, From 2016-10-01 |
| 2016-09-30 | $1.13 | -72.4% | 2018-11-29, From 2015-10-01 |
| 2015-09-30 | $4.09 | +127.2% | 2017-12-11, From 2014-10-01 |
| 2014-09-30 | $1.80 | n/m | 2016-12-09, From 2013-10-01 |
| 2013-09-30 | -$0.67 | n/m | 2015-12-11, From 2012-10-01 |
| 2012-09-30 | $1.13 | -14.4% | 2014-12-11, From 2011-10-01 |
| 2011-09-30 | $1.32 | n/a | 2013-12-18, From 2010-10-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | -$3.84 | n/m |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $0.15 | n/m |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | -$0.07 | n/m |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | -$3.18 | n/m |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | -$0.60 | n/m |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | -$0.87 | n/m |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$0.15 | n/m |
| Journey Medical Corp (DERM) | 2025-12-31 | -$0.47 | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$0.55 | n/m |
Compare ENTA, SPRO, FBIO, KURA side by side · Screen every company in Pharmaceutical Preparations ↗